Double-Negative T cells in SIV and HIV Infections

SIV 和 HIV 感染中的双阴性 T 细胞

基本信息

  • 批准号:
    8472130
  • 负责人:
  • 金额:
    $ 63.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2013-08-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Numerous African non-human primates, including the sooty mangabeys, are natural hosts of SIV and have co- evolved with their respective SIVs for at least 30,000 years. Studies of SIV infections in natural host species have dramatically influenced the way we think about AIDS pathogenesis in two fundamental ways. First, prevention of disease progression does not require suppression of virus replication, as natural SIV hosts remain free of clinical signs despite high levels of viremia. Second, the absence of AIDS correlates with low levels of systemic immune activation during chronic infection. The Sodora laboratory has established a cohort of SIV-infected mangabeys that unexpectedly developed severe CD4+ T cell depletion (CD4 blood levels are <80 cells/ul) but still do not progress to AIDS. These "CD4-low" animals challenge the current paradigm that very low CD4+ T cell counts are not compatible with long term survival. The key unanswered question that the SIV-infected CD4-low mangabey cohort invokes is: How do these sooty mangabeys maintain ostensibly normal T helper cell function with so few CD4+ T cells? In this proposal we will test the hypothesis that CD3+CD4-CD8- double-negative (DN) T cells provide basic T helper cell functions in CD4-low SIV-infected sooty mangabeys, allowing for maintenance of a normal immune system, whereas DN T cell function is sub- optimal during the CD4+ T cell depletion that follows pathogenic HIV/SIV infections in humans/macaques. DN T cells are inherently resistant to SIV infection due to the absence of the CD4 receptor. In addition to studying the function of these cells in sooty mangabeys, we will investigate the potential for DN T cells to function as helper cells during pathogenic HIV and SIV infections of humans and macaques. In previous studies, we have demonstrated that in CD4-low SIV-infected sooty mangabeys, DN T cells: (i) Are present at relatively high levels in peripheral blood both prior to and following an SIV infection; (ii) Can be SIV specific and produce cytokines in response to SIV peptide stimulation; (iii) Principally exhibit a central memory T cell phenotype; and (iv) Produce Th1, Th2 and Th17 cytokines. These preliminary data indicate that the DN T cells provide helper T cell like function that could assist in immune responses against both SIV and opportunistic pathogens in CD4-low mangabeys. The specific aims of the proposal will assess phenotype and function of DN T cells in SIV-infected mangabeys as well as in two pathogenic infections, SIV-infected macaques and HIV infected humans (Aim 1), as well as the ability of DN T cells to make antigen specific responses in immunized mangabeys (Aim 2). Ultimately, this work will provide the basic evaluations necessary to determine if a future immune therapeutic intervention to increase function of DN T cells during pathogenic HIV/SIV infections is possible. We envision that immune therapeutic approaches improving DN T cell function may provide a 'Functional Cure' in which HIV-infected individuals will achieve a non-pathogenic state that is similar to what we have documented in SIV-infected natural hosts.
描述(由申请人提供):许多非洲非人类灵长类动物,包括烟灰芒果,是SIV的天然寄主,并且已经与各自的SIV共同发展了至少30,000年。自然寄主物种中SIV感染的研究极大地影响了我们以两种基本方式对艾滋病发病机理的看法。首先,预防疾病进展并不需要抑制病毒复制,因为尽管病毒血症水平很高,但天然SIV宿主仍然没有临床体征。其次,缺乏艾滋病与慢性感染期间的全身免疫激活水平低有关。 Sodora实验室已经建立了一系列SIV感染的芒果,这些芒果意外形成了严重的CD4+ T细胞耗竭(CD4血液水平<80细胞/UL),但仍未发展为艾滋病。这些“ CD4-low”动物挑战了当前的范式,即非常低的CD4+ T细胞计数与长期存活不兼容。关键的未解决的问题是,感染了SIV的CD4-LOW MANGABEY队列引用的是:这些烟熏芒果如何在表面上保持正常的T辅助细胞功能,而CD4+ T细胞很少? In this proposal we will test the hypothesis that CD3+CD4-CD8- double-negative (DN) T cells provide basic T helper cell functions in CD4-low SIV-infected sooty mangabeys, allowing for maintenance of a normal immune system, whereas DN T cell function is sub- optimal during the CD4+ T cell depletion that follows pathogenic HIV/SIV infections in humans/macaques.由于缺乏CD4受体,DN T细胞对SIV感染具有固有的抗性。除了研究这些细胞在烟熏芒果中的功能外,我们还将研究DN T细胞在病原HIV和人类和猕猴的病原HIV和SIV感染期间充当辅助细胞的潜力。在先前的研究中,我们已经证明,在CD4-low SIV感染的烟灰芒果中,DN T细胞:(i)在外周血中都存在相对较高的水平。 SIV感染; (ii)可以是特异性的,并响应SIV肽刺激而产生细胞因子; (iii)主要表现出中央记忆T细胞表型; (iv)产生Th1,Th2 和Th17细胞因子。这些初步数据表明,DN T细胞提供了类似的辅助T细胞功能,可以帮助CD4-LOW MANGABEYS中的SIV和机会性病原体的免疫反应。该提案的具体目的将评估DN T细胞在SIV感染的芒果中的表型和功能,以及两种致病性感染,SIV感染的猕猴和HIV感染的人(AIM 1)以及DN T细胞在免疫植物中具有抗原特异性反应的能力(AIM 1)。最终,这项工作将提供必要的基本评估,以确定未来的免疫治疗干预措施是否可以在病原HIV/SIV感染过程中提高DN T细胞的功能。我们设想,改善DN T细胞功能的免疫治疗方法可能会提供“功能治愈”,其中HIV感染的个体将获得与类似于什么的非致病状态 我们已经记录了SIV感染的天然寄主。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald L Sodora其他文献

Donald L Sodora的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald L Sodora', 18)}}的其他基金

Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10330882
  • 财政年份:
    2021
  • 资助金额:
    $ 63.02万
  • 项目类别:
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10428674
  • 财政年份:
    2021
  • 资助金额:
    $ 63.02万
  • 项目类别:
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
感染 SIV 的幼年猕猴的疾病快速进展和病毒库形成
  • 批准号:
    10640931
  • 财政年份:
    2021
  • 资助金额:
    $ 63.02万
  • 项目类别:
Mediators of fatty liver disease during HIV/SIV and cART treatment
HIV/SIV 和 cART 治疗期间脂肪肝疾病的介质
  • 批准号:
    10329968
  • 财政年份:
    2018
  • 资助金额:
    $ 63.02万
  • 项目类别:
Mediators of fatty liver disease during HIV/SIV and cART treatment
HIV/SIV 和 cART 治疗期间脂肪肝疾病的介质
  • 批准号:
    10089216
  • 财政年份:
    2018
  • 资助金额:
    $ 63.02万
  • 项目类别:
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
HIV/SIV 暴露婴儿的新生儿疫苗接种风险
  • 批准号:
    8906840
  • 财政年份:
    2013
  • 资助金额:
    $ 63.02万
  • 项目类别:
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
HIV/SIV 暴露婴儿的新生儿疫苗接种风险
  • 批准号:
    9142317
  • 财政年份:
    2013
  • 资助金额:
    $ 63.02万
  • 项目类别:
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
HIV/SIV 暴露婴儿的新生儿疫苗接种风险
  • 批准号:
    8737221
  • 财政年份:
    2013
  • 资助金额:
    $ 63.02万
  • 项目类别:
Inhibition of Liver Macrophage activation in SIV infected macaques
SIV 感染猕猴肝脏巨噬细胞活化的抑制
  • 批准号:
    8466826
  • 财政年份:
    2013
  • 资助金额:
    $ 63.02万
  • 项目类别:
Inhibition of Liver Macrophage activation in SIV infected macaques
SIV 感染猕猴肝脏巨噬细胞活化的抑制
  • 批准号:
    8606812
  • 财政年份:
    2013
  • 资助金额:
    $ 63.02万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
  • 批准号:
    10762645
  • 财政年份:
    2023
  • 资助金额:
    $ 63.02万
  • 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
  • 批准号:
    10706874
  • 财政年份:
    2023
  • 资助金额:
    $ 63.02万
  • 项目类别:
Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE)
电子方式探索、预测和干预长期病毒抑制 (EPI-LoVE)
  • 批准号:
    10676683
  • 财政年份:
    2023
  • 资助金额:
    $ 63.02万
  • 项目类别:
KNUST Aging and HIV Outcomes
KNUST 老龄化和艾滋病毒结果
  • 批准号:
    10751613
  • 财政年份:
    2023
  • 资助金额:
    $ 63.02万
  • 项目类别:
MyPrEP Plus: Development and Pilot Testing of Novel Pre-Exposure Prophylaxis Support Tools for Transgender Women
MyPrEP Plus:针对跨性别女性的新型暴露前预防支持工具的开发和试点测试
  • 批准号:
    10618102
  • 财政年份:
    2023
  • 资助金额:
    $ 63.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了